Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of January 4, 2026

By / January 6, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

RECORLEV (levoketoconazole)

Strongbridge Patent: 11,478,471 Expiration: Jan 10, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Drug APIs Start Here: How to Nail Your KSM Strategy
The Patent Cliff's Shadow: Impact on Branded…
The Patent Playbook for Pharma: Protect Your Drug.…
The Final Countdown: A Strategic Guide to SPC Expiry…
Drug Repositioning: One Molecule. Two Indications.…
The Missing Ingredient: Why Patent Data Is the Key…
Effective Drug Patent Prosecution Strategies:…
Patent Term Extension Calculator: Step-by-Step Expert Guide
When should you outsource drug development: A…
The Crystal Ball of Pharma: Using Patent Expiry Data…
Navigating the Patent Maze: A CDMO's Guide to IP…
The Innovator's Compass: Navigating the Patent…
How to own a Market you Don't Own: Market Access…
Overcoming Formulation Challenges in Generic Drug…
The Patent-Powered Pitch: A Founder's Guide to…
Mastering the Generic Gambit: A Comprehensive…
8 Applications of Machine Learning in The…
Beyond the Prescription Pad: Why Patent Intelligence…
Unlocking the Potential of Abandoned and Expired…
Pharmacists: Unlocking Market Domination Through…
The 92-Day Pill Puzzle: Why Your 3-Month Supply…
The Patent Playbook Your Lawyers Won’t Write: Patent…
Transforming Expired and Abandoned Patents into a…
AI-Driven Strategies: Pharma's Answer to Patent Expirations

Beyond Patents: The Next Evolution in Pharmaceutical Investing

A Strategic Guide to Maximizing Biologic Market Exclusivity

Related Posts

Drug Patent Expirations for the Week of August 10, 2025

Patent Expiration / By

Drug Patent Expirations for the Week of August 17, 2025

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Mastering the Dance: A Strategic Guide to the BPCIA Biosimilar Patent Timeline and Litigation
A Strategic Playbook for Timing ANDA Submissions Using Drug Patent Data
The Pharmaceutical Industry in South Africa and Nigeria: A Strategic Analysis of Industry and Regulatory Frameworks and Global Commercial Potential
Navigating the Exclusivity of Biologics and Small Molecules for Competitive Advantage
Breaking Through the Maze of Biologic Drug Patents: A Strategic Guide for Innovators, Developers, and Investors

Popular Posts

A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
Pfizer’s Portfolio as a Model for Precision in Pharma Investments
The Role of China in the Global Generic Drug API Market
PBMs, Formularies, and Rebates: What Investors Should Know
The Rise of Telehealth Companies Like Ro and Hims & Hers: How Direct-to-Consumer Telehealth Redefined the Pharmaceutical Value Chain
How Long Does a Patent Last for Drugs? A Comprehensive Guide to Pharmaceutical Patent Duration
Licensing Agreements in the Pharmaceutical Sector
A Strategic Investor’s Guide to Pharmaceutical Portfolio Risk Assessment
Navigating the Exclusivity of Biologics and Small Molecules for Competitive Advantage

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on January 6, 2026 by